Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.35 - $3.28 $15,353 - $143,883
43,867 Added 3.77%
1,207,728 $422,000
Q1 2023

May 15, 2023

BUY
$3.28 - $4.81 $676,844 - $992,567
206,355 Added 21.55%
1,163,861 $4.03 Million
Q4 2022

Feb 14, 2023

BUY
$3.65 - $4.82 $847,533 - $1.12 Million
232,201 Added 32.01%
957,506 $4.29 Million
Q3 2022

Nov 14, 2022

BUY
$2.66 - $3.97 $235,410 - $351,345
88,500 Added 13.9%
725,305 $2.64 Million
Q2 2022

Aug 15, 2022

SELL
$2.42 - $4.05 $923,305 - $1.55 Million
-381,531 Reduced 37.47%
636,805 $1.69 Million
Q1 2022

May 16, 2022

BUY
$3.45 - $5.83 $2.49 Million - $4.22 Million
723,052 Added 244.87%
1,018,336 $3.99 Million
Q4 2021

Feb 14, 2022

BUY
$4.89 - $7.59 $783,813 - $1.22 Million
160,289 Added 118.74%
295,284 $1.63 Million
Q3 2021

Nov 15, 2021

SELL
$5.18 - $7.41 $1.52 Million - $2.17 Million
-293,417 Reduced 68.49%
134,995 $973,000
Q2 2021

Aug 16, 2021

BUY
$3.94 - $6.75 $1.57 Million - $2.7 Million
399,315 Added 1372.36%
428,412 $2.83 Million
Q1 2021

May 17, 2021

SELL
$4.03 - $7.25 $1.27 Million - $2.28 Million
-314,415 Reduced 91.53%
29,097 $127,000
Q4 2020

Feb 16, 2021

BUY
$2.78 - $4.5 $884,815 - $1.43 Million
318,279 Added 1261.36%
343,512 $1.31 Million
Q3 2020

Nov 16, 2020

SELL
$2.12 - $3.53 $92,741 - $154,423
-43,746 Reduced 63.42%
25,233 $88,000
Q2 2020

Aug 14, 2020

SELL
$1.66 - $2.73 $97,636 - $160,570
-58,817 Reduced 46.02%
68,979 $155,000
Q1 2020

May 15, 2020

BUY
$1.35 - $4.05 $1,374 - $4,122
1,018 Added 0.8%
127,796 $319,000
Q4 2019

Feb 14, 2020

BUY
$2.3 - $4.6 $204,111 - $408,222
88,744 Added 233.33%
126,778 $535,000
Q3 2019

Nov 14, 2019

BUY
$2.9 - $9.56 $61,848 - $203,886
21,327 Added 127.65%
38,034 $110,000
Q2 2019

Aug 14, 2019

SELL
$6.7 - $9.13 $84,433 - $115,056
-12,602 Reduced 43.0%
16,707 $147,000
Q1 2019

May 15, 2019

SELL
$5.7 - $8.73 $422,090 - $646,465
-74,051 Reduced 71.64%
29,309 $0
Q3 2018

Nov 13, 2018

BUY
$7.12 - $12.44 $577,944 - $1.01 Million
81,172 Added 365.84%
103,360 $0
Q2 2018

Aug 10, 2018

SELL
$6.21 - $8.21 $47,599 - $62,929
-7,665 Reduced 25.68%
22,188 $0
Q1 2018

May 11, 2018

SELL
$6.26 - $10.12 $4 Million - $6.47 Million
-639,201 Reduced 95.54%
29,853 $192,000
Q4 2017

Feb 09, 2018

BUY
$5.6 - $9.9 $3.58 Million - $6.32 Million
638,854 Added 2115.41%
669,054 $6.2 Million
Q3 2017

Nov 09, 2017

BUY
$4.73 - $6.16 $142,846 - $186,032
30,200
30,200 $174,000

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.